Platform for End-of-life Awareness, Conversations, and Education (PEACE) Among Registered Nurses
17 de agosto de 2026 actualizado por: Ang Wei How Darryl, National University of Singapore
Platform for End-of-life Awareness, Conversations, and Education (PEACE) Among Registered Nurses: A Mixed Methods Study
The goal of this clinical trial is to evaluate whether the PEACE program can improve early career registered nurses' registered nurses' attitudes towards caring for palliative patients, ability to cope with patients' death, and self-efficacy in initiating advanced care planning conversations
This study aims to address the following research questions:
- Does the PEACE program improve early career registered nurses' attitudes towards caring for palliative patients, ability to cope with patients' death and self-efficacy in initiating advanced care planning conversations?
- What are the participants' experiences of participating in the PEACE program?
Researchers will compare participants who receive the PEACE program (death conversation and online ACP education) with participants who receive only the online ACP education to see if informal death conversations improve early career registered nurses' attitudes towards caring for palliative patients, ability to cope with patients' death and self-efficacy in initiating advanced care planning conversations.
Participants will:
- Complete online questionnaires measuring attitudes towards caring for palliative patients, ability to cope with patients' death and self-efficacy in initiating advanced care planning conversations.
- Participate in a facilitator-led group discussion session about experiences of patients' deaths, coping with patients' death and dying, communications with patients and/or family members about death and dying, and discussing advance care planning with patients and/or family members (intervention group only).
- Complete an asynchronous online ACP education session consisting of short recorded videos and an online discussion forum (both intervention and control group).
- Complete follow-up surveys, including a 3-month follow-up assessing whether participants have engage with any patients and/or their family members in advance care planning conversations.
Descripción general del estudio
Estado
Aún no reclutando
Condiciones
Intervención / Tratamiento
Tipo de estudio
Intervencionista
Inscripción (Estimado)
150
Fase
- No aplica
Contactos y Ubicaciones
Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.
Estudio Contacto
- Nombre: Darryl Ang, PhD
- Número de teléfono: +65 65167792
- Correo electrónico: darrylang@nus.edu.sg
Ubicaciones de estudio
-
-
-
Singapore, Singapur
- National University of Singapore
-
Contacto:
- Darryl Ang, PhD
- Número de teléfono: +65 65167792
- Correo electrónico: darrylang@nus.edu.sg
-
-
Criterios de participación
Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto
- Adulto Mayor
Acepta Voluntarios Saludables
Sí
Descripción
Inclusion Criteria:
- Registered nurses within the first five years of practice
- Between the ages of 21 to 65 years
- Currently working in a healthcare setting in SIngapore
Exclusion Criteria:
- Participated in a similar death conversation program
- Received training in Advance Care Planning or Serious Illness Conversations
- Any self-reported history of mental health disorders (e.g., depression), or neurological disorders (e.g., brain tumors)
Plan de estudios
Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Prevención
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Intervention Group - on site group discussions + online learning session
Participants in this arm will receive the two-session PEACE Program. Session 1 is an on site, facilitator-led group discussion lasting 2 hours, covering:
Session 2 is an online asynchronous learning session with short videos on ACP with discussion forums. |
Una sesión de aprendizaje asíncrona en línea con vídeos cortos sobre ACP y foros de discusión.
On site, facilitator-led group discussion lasting 2 hours, covering: 1) Experiences of patients' deaths; 2) Coping with patients' death and dying; 3) Communication with patients and/or family members about death and dying; 4) Discussing advance care planning with patients and/or family members
|
|
Comparador activo: Control Group - Only online learning session
Participants in this arm will only receive the online ACP education component, identical to Session 2 of the PEACE programme.
No facilitator-led group discussions are provided.
|
Una sesión de aprendizaje asíncrona en línea con vídeos cortos sobre ACP y foros de discusión.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Frommelt Attitude Toward Care of the Dying Scale
Periodo de tiempo: Baseline
|
A 30-item 5 point Likert scale.
Positive items are scored one (strongly disagree) to five (strongly agree).
Scores are reversed for negative items.
Possible scores can range from 30-150.
A higher score indicates a more positive attitude toward caring for this patient population.
|
Baseline
|
|
Frommelt Attitude Toward Care of the Dying Scale
Periodo de tiempo: Post-test (Immediately at end of 2-weeks intervention)
|
A 30-item 5 point Likert scale.
Positive items are scored one (strongly disagree) to five (strongly agree).
Scores are reversed for negative items.
Possible scores can range from 30-150.
A higher score indicates a more positive attitude toward caring for this patient population.
|
Post-test (Immediately at end of 2-weeks intervention)
|
|
Frommelt Attitude Toward Care of the Dying Scale
Periodo de tiempo: 3 months follow-up
|
A 30-item 5 point Likert scale.
Positive items are scored one (strongly disagree) to five (strongly agree).
Scores are reversed for negative items.
Possible scores can range from 30-150.
A higher score indicates a more positive attitude toward caring for this patient population.
|
3 months follow-up
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Palliative care self-efficacy scale
Periodo de tiempo: Baseline
|
A twelve item 4-point Likert scale, scored from 1 (Need further basic instruction) to 4 (Confident to perform independently).
Higher scores indicate nurses having higher degree of confidence with the respective patient/family interactions and patient management topics.
|
Baseline
|
|
Palliative care self-efficacy scale
Periodo de tiempo: Post-test (Immediately at end of 2-weeks intervention)
|
A twelve item 4-point Likert scale, scored from 1 (Need further basic instruction) to 4 (Confident to perform independently).
Higher scores indicate nurses having higher degree of confidence with the respective patient/family interactions and patient management topics.
|
Post-test (Immediately at end of 2-weeks intervention)
|
|
Palliative care self-efficacy scale
Periodo de tiempo: 3 months follow-up
|
A twelve item 4-point Likert scale, scored from 1 (Need further basic instruction) to 4 (Confident to perform independently).
Higher scores indicate nurses having higher degree of confidence with the respective patient/family interactions and patient management topics.
|
3 months follow-up
|
|
Advance Care Planning Self-Efficacy (ACP-SE) Scale
Periodo de tiempo: Baseline
|
An 18-item 5-point Likert scale, scored from 1 (Not at all confident) to 5 (Very confident), with higher scores indicating more confidence in performing respective tasks regarding Advance Care Planning (ACP) conversations for patients.
|
Baseline
|
|
Advance Care Planning Self-Efficacy (ACP-SE) Scale
Periodo de tiempo: Post-test (Immediately at end of 2-weeks intervention)
|
An 18-item 5-point Likert scale, scored from 1 (Not at all confident) to 5 (Very confident), with higher scores indicating more confidence in performing respective tasks regarding Advance Care Planning (ACP) conversations for patients.
|
Post-test (Immediately at end of 2-weeks intervention)
|
|
Advance Care Planning Self-Efficacy (ACP-SE) Scale
Periodo de tiempo: 3 months follow-up
|
An 18-item 5-point Likert scale, scored from 1 (Not at all confident) to 5 (Very confident), with higher scores indicating more confidence in performing respective tasks regarding Advance Care Planning (ACP) conversations for patients.
|
3 months follow-up
|
|
End-of-life planning conversations
Periodo de tiempo: 3 months follow-up
|
Self-reported number of conversations held with patients regarding Advance Care Planning
|
3 months follow-up
|
Colaboradores e Investigadores
Aquí es donde encontrará personas y organizaciones involucradas en este estudio.
Patrocinador
Fechas de registro del estudio
Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.
Fechas importantes del estudio
Inicio del estudio (Estimado)
1 de septiembre de 2026
Finalización primaria (Estimado)
31 de diciembre de 2027
Finalización del estudio (Estimado)
31 de diciembre de 2027
Fechas de registro del estudio
Enviado por primera vez
11 de agosto de 2026
Primero enviado que cumplió con los criterios de control de calidad
17 de agosto de 2026
Publicado por primera vez (Actual)
19 de agosto de 2026
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
19 de agosto de 2026
Última actualización enviada que cumplió con los criterios de control de calidad
17 de agosto de 2026
Última verificación
1 de agosto de 2026
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- NUS-DERC-001647
- A-0010425-00-00 (Otro número de subvención/financiamiento: National University of Singapore)
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
No
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
No
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .